These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9808514)

  • 1. Selective antitumor activity of MKT-077, a delocalized lipophilic cation, on normal cells and cancer cells in vitro.
    Chiba Y; Kubota T; Watanabe M; Otani Y; Teramoto T; Matsumoto Y; Koya K; Kitajima M
    J Surg Oncol; 1998 Oct; 69(2):105-10. PubMed ID: 9808514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent.
    Tatsuta N; Suzuki N; Mochizuki T; Koya K; Kawakami M; Shishido T; Motoji N; Kuroiwa H; Shigematsu A; Chen LB
    Cancer Chemother Pharmacol; 1999; 43(4):295-301. PubMed ID: 10071980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation.
    Koya K; Li Y; Wang H; Ukai T; Tatsuta N; Kawakami M; Shishido ; Chen LB
    Cancer Res; 1996 Feb; 56(3):538-43. PubMed ID: 8564968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units.
    Petit T; Izbicka E; Lawrence RA; Nalin C; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Mar; 10(3):309-15. PubMed ID: 10327038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the antiproliferative activity of MKT-077 by loperamide, diltiazem and tamoxifen.
    Abdul M; Hoosein N
    Oncol Rep; 2003; 10(6):2023-6. PubMed ID: 14534737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MKT-077, localized lipophilic cation: antitumor activity against human tumor xenografts serially transplanted into nude mice.
    Chiba Y; Kubota T; Watanabe M; Matsuzaki SW; Otani Y; Teramoto T; Matsumoto Y; Koya K; Kitajima M
    Anticancer Res; 1998; 18(2A):1047-52. PubMed ID: 9615763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077.
    Modica-Napolitano JS; Koya K; Weisberg E; Brunelli BT; Li Y; Chen LB
    Cancer Res; 1996 Feb; 56(3):544-50. PubMed ID: 8564969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077.
    Tikoo A; Shakri R; Connolly L; Hirokawa Y; Shishido T; Bowers B; Ye LH; Kohama K; Simpson RJ; Maruta H
    Cancer J; 2000; 6(3):162-8. PubMed ID: 10882332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo.
    Starenki D; Park JI
    Endocrinol Metab (Seoul); 2015 Dec; 30(4):593-603. PubMed ID: 26485469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoactivation enhances the mitochondrial toxicity of the cationic rhodacyanine MKT-077.
    Modica-Napolitano JS; Brunelli BT; Koya K; Chen LB
    Cancer Res; 1998 Jan; 58(1):71-5. PubMed ID: 9426060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased drug resistance of cultured human cancer cell lines in three-dimensional cellular growth assay using collagen gel matrix.
    Furukawa T; Kubota T; Watanabe M; Kase S; Saikawa Y; Nishibori H; Kuo TH; Kodaira S; Ishibiki K; Kitajima M
    J Surg Oncol; 1992 Feb; 49(2):86-92. PubMed ID: 1738241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferons alpha-2a and beta increase the antitumor activity, detected by MTT assay, of 5-fluorouracil against experimental and clinical human gastrointestinal carcinomas.
    Kubota T; Kase S; Otani Y; Watanabe M; Teramoto T; Kitajima M
    Anticancer Res; 1997; 17(1B):725-8. PubMed ID: 9066609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077.
    Britten CD; Rowinsky EK; Baker SD; Weiss GR; Smith L; Stephenson J; Rothenberg M; Smetzer L; Cramer J; Collins W; Von Hoff DD; Eckhardt SG
    Clin Cancer Res; 2000 Jan; 6(1):42-9. PubMed ID: 10656430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor activity of an antibiotic peptide derived from apoprotein E.
    Kojima T; Fujimitsu Y; Kojima H
    In Vivo; 2005; 19(1):261-4. PubMed ID: 15796184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones.
    Rousaki A; Miyata Y; Jinwal UK; Dickey CA; Gestwicki JE; Zuiderweg ER
    J Mol Biol; 2011 Aug; 411(3):614-32. PubMed ID: 21708173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent antitumor spectrum of UCN-01 (7-hydroxystaurosporine) against gastric and colorectal cancers as detected by MTT assay.
    Abe S; Kubota T; Saikawa Y; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2002; 22(6B):3605-10. PubMed ID: 12552963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective in vitro cytotoxicity of carcinoma cells by AZT is enhanced by concurrent treatment with delocalized lipophilic cations.
    Modica-Napolitano JS; Nalbandian R; Kidd ME; Nalbandian A; Nguyen CC
    Cancer Lett; 2003 Jul; 198(1):59-68. PubMed ID: 12893431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.
    Bradshaw TD; Wrigley S; Shi DF; Schultz RJ; Paull KD; Stevens MF
    Br J Cancer; 1998 Mar; 77(5):745-52. PubMed ID: 9514053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supra-additive antitumor activity of 5FU with tumor necrosis factor-related apoptosis-inducing ligand on gastric and colon cancers in vitro.
    Shimoyama S; Mochizuki Y; Kusada O; Kaminishi M
    Int J Oncol; 2002 Sep; 21(3):643-8. PubMed ID: 12168112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.